Literature DB >> 15929867

Stroke prevention in diabetic and other high cardiovascular risk patients.

Fadi El-Atat1, Tanja Rundek, James R Sowers, Samy I McFarlane.   

Abstract

Diabetes is a major risk factor for stroke that is usually associated with risk factors such as hypertension, obesity, albuminuria, and dyslipidemia. Furthermore, atrial fibrillation and heart failure, two of the most important risk factors of stroke, are common in the diabetic population. With the rising epidemic of diabetes, the incidence of stroke is also on the rise. Implementations of effective stroke prevention strategies appear to be the most rational option to curb this growing epidemic. In this review, we examine the epidemiologic and the pathophysiologic association between stroke and diabetes, highlighting the population-based stroke preventive measures. These include hygienic and lifestyle changes, that if applied effectively could offer a great potential for stroke prevention and reduction of the cardiovascular burden in the diabetic populations.

Entities:  

Mesh:

Year:  2005        PMID: 15929867     DOI: 10.1007/s11892-005-0010-7

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   4.810


  92 in total

1.  Endovascular versus surgical treatment in patients with carotid stenosis in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): a randomised trial.

Authors: 
Journal:  Lancet       Date:  2001-06-02       Impact factor: 79.321

2.  Effect of hyperglycemia on brain pH levels in areas of focal incomplete cerebral ischemia in monkeys.

Authors:  W R Marsh; R E Anderson; T M Sundt
Journal:  J Neurosurg       Date:  1986-11       Impact factor: 5.115

3.  Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators.

Authors: 
Journal:  Lancet       Date:  2000-01-22       Impact factor: 79.321

4.  Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group.

Authors: 
Journal:  JAMA       Date:  1991-06-26       Impact factor: 56.272

5.  Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.

Authors:  Lars H Lindholm; Hans Ibsen; Björn Dahlöf; Richard B Devereux; Gareth Beevers; Ulf de Faire; Frej Fyhrquist; Stevo Julius; Sverre E Kjeldsen; Krister Kristiansson; Ole Lederballe-Pedersen; Markku S Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel; Peter Aurup; Jonathan Edelman; Steven Snapinn
Journal:  Lancet       Date:  2002-03-23       Impact factor: 79.321

Review 6.  Present treatment options for atrial fibrillation.

Authors:  S K S Lairikyengbam; M H Anderson; A G Davies
Journal:  Postgrad Med J       Date:  2003-02       Impact factor: 2.401

7.  Changes in extra- and intracellular pH in the brain during and following ischemia in hyperglycemic and in moderately hypoglycemic rats.

Authors:  M L Smith; R von Hanwehr; B K Siesjö
Journal:  J Cereb Blood Flow Metab       Date:  1986-10       Impact factor: 6.200

8.  Diabetes as a risk factor for stroke. A population perspective.

Authors:  B Stegmayr; K Asplund
Journal:  Diabetologia       Date:  1995-09       Impact factor: 10.122

Review 9.  A cardiologist in the carotids.

Authors:  William A Gray
Journal:  J Am Coll Cardiol       Date:  2004-05-05       Impact factor: 24.094

10.  Increased damage after ischemic stroke in patients with hyperglycemia with or without established diabetes mellitus.

Authors:  W A Pulsinelli; D E Levy; B Sigsbee; P Scherer; F Plum
Journal:  Am J Med       Date:  1983-04       Impact factor: 4.965

View more
  1 in total

1.  Measurement of subclinical carotid atherosclerosis may help in predicting risk for stroke in patients with diabetes.

Authors:  David Della-Morte; Camillo Ricordi; Fiorella Guadagni; Tatjana Rundek
Journal:  Metab Brain Dis       Date:  2013-02-10       Impact factor: 3.584

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.